Ann: Appendix 4C - quarterly, page-39

Ladies and Gents,
I have just spent the last 3 hours researching Stemcell from it popping up in a scan.
The experienced heads are talking on the threads here which is nice.
Its research and facts not pie in the sky.
The share price certainly seems wound up like a clock and about to spring into a valuation that's a lot closer to the last 1/4ly revenue. The late run to the last close Friday is solid.
$17m MC currently at 2c, relate that to its peers in the Cannabis space for a PE.
This on top of the Sea Grapes element. I trust the revenue will remain constant and with luck expandable as the opportunities present themselves for growth.
Will be looking to enter asap and follow the story with very close interest well into the future.
Paul Rosen. Far Out!!! That's some Non-Exec Chairman!!!
It can only open doors and create opportunities.